Novel antibody-drug conjugate demonstrates durable responses in patients with platinum-resistant ovarian cancer
October 08, 2026
October 08, 2026
BOSTON, Massachusetts, Oct. 8 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
Novel antibody-drug conjugate demonstrates durable responses in patients with platinum-resistant ovarian cancer
*
An investigational antibody-drug conjugate demonstrated clinically meaningful and durable responses in patients with platinum-resistant ovarian cancer, including patients whose tumors had low or no expre . . .
* * *
Novel antibody-drug conjugate demonstrates durable responses in patients with platinum-resistant ovarian cancer
*
An investigational antibody-drug conjugate demonstrated clinically meaningful and durable responses in patients with platinum-resistant ovarian cancer, including patients whose tumors had low or no expre . . .